ArticleMicrobial cell factories2025
Cis,cis-muconic acid production from lignin related molecules byAcinetobacter baylyi ADP1.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Conversion and upgrading of syringate by Acinetobacter baylyi ADP1.Microbial cell factories · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCis,cis-muconic acid (ccMA), an important platform chemical, can be produced from lignin related molecules (LRM) via a specific two-branch catabolic route known as the β-ketoadipate pathway, which is present in certain soil bacteria. This pathway enables high production yields because ccMA is a native intermediate in one of its branches. However, commonly obtained LRM, such as p-coumaric and ferulic acid, are typically metabolized through the branch that lacks the ccMA intermediate. To redirect these LRM toward ccMA production, the two branches must be functionally integrated. This is usually achieved by introducing a non-native enzymatic activity, specifically protocatechuate decarboxylase (PCADC), which catalyzes the conversion of protocatechuate to catechol. Nevertheless, this conversion often represents the rate-limiting step in the production process.
resultsHere, we established a growth-coupled selection system for screening PCADCs using the soil bacterium Acinetobacter baylyi ADP1 as the host. In this system, cell growth depends on the in vivo performance of PCADC, thereby enabling the selection of the optimal candidate for further ccMA production. In total, five PCADC candidates were screened. AGDC1, a gallic acid decarboxylase from the yeast Blastobotrys adeninivorans, was selected for production studies. In fed-batch cultivations, the engineered strain expressing AGDC1 achieved an 83% molar yield of ccMA from ferulate and p-coumarate, that were found in lignin hydrolysate derived from straw.
conclusionIn this study, we established a growth-based selection system for PCADCs. The outcome of the selection system was further validated in production cultivations using an engineered A. baylyi ADP1 strain. This study not only confirms the feasibility of AGDC1 in ccMA production in bacterial systems but also provides a practical screening system for future improvements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.